Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: KDMN CCIV PTON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Friday, 14 May 2021 06:10 AM

The Law Offices of Vincent Wong

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / May 14, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Kadmon Holdings, Inc. (NASDAQ:KDMN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=15855&wire=1
Lead Plaintiff Deadline: June 2, 2021
Class Period: October 1, 2020 - March 10, 2021

Allegations against KDMN include that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Churchill Capital Corp IV (NYSE:CCIV)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?prid=15855&wire=1
Lead Plaintiff Deadline: June 18, 2021
Class Period: January 11, 2021 - February 22, 2021

Allegations against CCIV include that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

Peloton Interactive, Inc. (NASDAQ:PTON)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/peloton-interactive-inc-loss-submission-form?prid=15855&wire=1
Lead Plaintiff Deadline: June 28, 2021
Class Period: September 11, 2020 - April 16, 2021

Allegations against PTON include that: (1) in addition to the tragic death of a child, Peloton's Tread+ had caused a serious safety threat to children and pets as there were multiple incidents of injury to both; (2) safety was not a priority to Peloton as defendants were aware of serious injuries and death resulting from the Tread+, yet did not recall or suggest a halt of the use of the Tread+; (3) as a result of the safety concerns, the U.S. Consumer Product Safety Commission ("CPSC") declared that the Tread+ posed a serious risk to public health and safety and urgently recommended that consumers with small children cease using the Tread+; (4) the CPSC also found a safety threat to Tread+ users if they lost their balance; and (5) as a result of the foregoing, defendants' statements about Peloton's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

The Law Offices of Vincent Wong, Friday, May 14, 2021, Press release picture

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: